We are a science-led global healthcare company. We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare.
We have a significant global presence with commercial operations in more than 150 countries, a network of 89 manufacturing sites, and large R&D centres in the UK, USA, Belgium and China.
The business is focused around the delivery of three strategic priorities which aim to increase growth, reduce risk and improve our long-term financial performance. These priorities are: grow a balanced global business, deliver more products of value, and simplify the operating model.
Operating responsibly and ensuring our values are embedded in our culture and decision-making helps us better meet the expectations of society.
Grow a balanced business
We have been creating a more balanced business and product portfolio, capable of delivering sustainable sales and earnings growth and improved returns to shareholders.
This is centred on our three business areas of Pharmaceuticals, Vaccines and Consumer Healthcare.
Group turnover outside USA and Europe
Deliver more products of value
We have changed our R&D organisation so that it is better able to sustain a pipeline of products that offer valuable improvements in treatment for patients and healthcare providers.
This is underpinned by a focus on improving productivity and rates of return in R&D.
Potential to file up to 20 assets by 2020
new potential medicines and vaccines in our pipeline profiled at R&D event in November 2015
of which we believe are potentially first-in-class
Simplify the operating model
As our business continues to change shape, we are transforming how we operate so that we can reduce complexity and become more efficient.
This frees up resources to reinvest elsewhere in the business, or return to shareholders wherever we see the most attractive returns.
Create a culture of individual empowerment
We are building a culture where employees are empowered, united by our values and able to achieve great things.
We are committed to operating responsibly and ensuring that our behaviour and actions meet or exceed the expectations of society.
Find out more about us
What we do
We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare
Corporate Executive Team
The Corporate Executive Team manages our activities, and each member is responsible for a specific part of the business
What we are working on
GSK has a deep portfolio of innovation, focussed across six core areas of scientific research and development
Behind the science
Discover more about what we do, the people behind GSK and how we are working to help change the face of healthcare